Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with advanced (stage II–IV) ovarian, fallopian tube, or peritoneal cancer, based on scans, a blood test called CA125, and a doctor's assessment
- You are scheduled to have open abdominal (exploratory) surgery to remove as much of the cancer as possible
- Your surgery is planned at least 10 days from now, allowing enough time to take the study medications for 7 days before the operation
- You are 18 years of age or older
- Your general fitness for surgery has been rated at a low to moderate level by your medical team (ASA score 1–3) (confirm with trial site)
- You are able to understand what the study involves, follow the study plan, and give your written consent to participate
Who may not be able to join:
- You are already taking a beta-blocker or COX inhibitor medication on a regular basis
- You have a medical condition that makes taking beta-blocker medication unsafe for you, such as asthma, certain heart rhythm problems, heart failure, or certain circulation problems (confirm with trial site)
- You have a medical condition that makes taking a COX2 inhibitor medication unsafe, such as kidney problems, significant liver disease, a stomach ulcer, or you are currently taking blood-thinning tablets
- You have a condition that means you cannot safely have a type of pain relief called an epidural
- You have a long-term autoimmune disease
- You currently have an active infection
- You are pregnant
- Your surgery is planned as a minimally invasive (keyhole) procedure rather than open surgery
- You are already taking part in another clinical trial that could affect this study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kara Long Roche, MD, Memorial Sloan Kettering Cancer Center
Phone: 212-639-7043
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants successfully completing over 80% of the bundled interventions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.